First Trust · holdings as of 2026-10-12

ROBT

First Trust Nasdaq Artificial Intelligence and Robotics ETF

Last / close
$59.08
Day change
-$0.28 · -0.47%
Volume
15.5K
NAV
Not reported
Premium / discount
Not reported
After hours · updated 16:15:00 ET · As of Oct 13, 2026, 4:15 PM EDTMarket quote receipt →

Companies participating in AI, robotics, and automation across enablers, engagers, and enhancers.

Veridion read
48Middle range · medium confidence
Fund score · valuation-exempt

4/5 applicable factors · 2026-10-13 · methodology receipt

Published holdings
112
Primary source
Issuer fund page →
01

Fund observations

Market and fund figures, each dated to its source.

A blank cell means the field does not have a qualified source. Price-derived AUM change is never relabeled as fund flow.

AUM
$778.2M
2026-10-12
Expense ratio
0.65%
2026-10-12
Inception
2018-02-21
2026-10-12
Holdings
112
2026-10-12
YTD return
+12.62%
2026-10-13
1Y return
+7.63%
2026-10-13

Every weight here comes straight from the issuer's filing — not our estimate.

02

Complete issuer book

All 112 holdings

Every row resolves to the issuer file dated 2026-10-12. Paid overlays add Scores and historical weight changes without altering the public holdings structure.

Public disclosures

Congress activity in ROBT

No receipt-qualified filings found.

03

Comparative read

Weight-adjusted Score and shared-book overlap.

The fund Score is a weighted aggregation of covered holdings, not a separately trained ETF model. Overlap uses only published issuer books.

01AIQ25.57%33 shared holdings
02XLK19.66%28 shared holdings
03IGV13.74%19 shared holdings
04ARKQ13.63%14 shared holdings
05ROBO13.63%17 shared holdings
06CIBR13.63%13 shared holdings
07CHAT12.86%14 shared holdings
08SMH12.35%14 shared holdings

Coverage note. Net flows, AUM change are not reported with a qualified receipt; 112 holding quotes are unresolved; the Score and ownership-change overlays are withheld from the free response. Open the issuer holdings receipt →

Veridion by email

Disclosure findings, methodology notes, and product updates when we have them. No fixed schedule yet. No advertising list resale.